For institutional and academic research facilities looking to buy GHK-Cu 100mg in the USA, establishing reliable sourcing backed by rigorous analytical verification is critical. PX1 Research supplies high-purity copper tripeptide-1 featuring lot-specific documentation for advanced in vitro and preclinical investigation.
For institutional and academic research facilities looking to buy GHK-Cu 100mg in the USA, establishing reliable sourcing backed by rigorous analytical verification is critical. PX1 Research supplies high-purity copper tripeptide-1 featuring lot-specific documentation for advanced in vitro and preclinical investigation.
To buy GHK-Cu 100mg in the USA for controlled laboratory research, principal investigators require analytical validation, documented lot traceability, and reliable domestic dispatch. PX1 Research manufactures and supplies research-grade GHK-Cu (copper tripeptide-1) at >98% purity verified via RP-HPLC and mass spectrometry. Every 100mg vial undergoes endotoxin screening and ships same-day from ISO 17025-compliant facilities in California and Arizona.
When purchasing laboratory compounds for cellular assays or histological models, obtaining raw materials with confirmed molecular identity and heavy metal limits is mandatory. Incomplete peptide coupling or free copper contamination can compromise experimental reproducibility. Researchers can review our full inventory of verified research peptides or inspect the specific GHK-Cu 100mg product page for complete certificate of analysis (COA) data.
Domestic sourcing ensures that sensitive lyophilized peptides maintain structural integrity during transit without exposure to extended customs holds or uncontrolled temperature variations. PX1 Research provides domestic researchers with direct access to US-manufactured compounds designed specifically for rigorous quantitative protocols.
GHK-Cu, systematically known as copper glycyl-L-histidyl-L-lysine, is a naturally occurring human plasma tripeptide complexed with a divalent copper ion (Cu2+). Discovered during early plasma fraction isolation experiments, the small peptide sequence displays a remarkably high affinity for copper, forming a stable coordination complex that acts as a vital signaling carrier in biological systems.
The molecular weight of the uncomplexed GHK peptide is approximately 340.38 g/mol, which increases upon chelation with copper to form the active GHK-Cu complex. The histidine residue plays a central role in coordinating the copper ion, forming a square planar structure that stabilized the complex under physiological pH. This unique structure facilitates interaction with specific cell surface receptors and extracellular matrix (ECM) proteins.
In controlled laboratory setups, understanding the stoichiometry of the GHK-Cu complex is vital. The tripeptide binds copper in a 1:1 molar ratio. In vitro assays demonstrate that the presence of the bound copper atom is mandatory for its specific biological activities, including transcription factor modulation and enzyme up-regulation, which are absent when administering uncomplexed GHK tripeptide alone.
A primary focus of GHK-Cu investigation centers on its capacity to modulate extracellular matrix gene expression. Preclinical studies using cultured dermal fibroblasts indicate that exposure to nanomolar concentrations of GHK-Cu significantly upregulates messenger RNA (mRNA) expression for fundamental structural proteins, notably type I collagen (COL1A1) and type III collagen (COL3A1).
In addition to collagenous networks, in vitro models demonstrate enhanced tropoelastin gene expression and subsequent assembly into functional elastin fibers. Elastin provides structural resilience to soft tissues, and its synthesis is typically limited in mature cell cultures. By promoting the activation of lysyl oxidase (LOX)—a copper-dependent enzyme responsible for cross-linking collagen and elastin—GHK-Cu supports the structural stabilization of synthesized matrix components.
Researchers evaluating extracellular matrix kinetics utilize GHK-Cu to observe the temporal dynamics of structural protein accumulation. Comparative cell culture assays reveal that GHK-Cu exhibits stronger stimulatory effects on fibroblast procollagen synthesis than established control compounds such as ascorbic acid or retinoic acid. Detailed biochemical pathways are further documented across our GHK-Cu mechanism research library.
Tissue remodeling requires a delicate equilibrium between matrix synthesis and degradation. Preclinical literature demonstrates that GHK-Cu acts as a dynamic regulator of matrix metalloproteinases (MMPs), particularly MMP-1, MMP-2, and MMP-9, alongside their natural inhibitors, tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2).
Through this dual regulatory action, GHK-Cu does not merely stimulate uncontrolled matrix accumulation; rather, it promotes balanced ECM turnover. In vitro studies on keloid and normal fibroblast lines show that GHK-Cu can downregulate excessive TGF-beta1 expression while modulating secondary messengers, thereby helping maintain normal tissue architecture during repair processes.
Furthermore, GHK-Cu has been observed to stimulate the production of cell-surface glycosaminoglycans, including heparan sulfate and dermatan sulfate. These proteoglycans are vital for cell attachment, growth factor sequestration, and maintaining hydration within the interstitial space in organotypic skin culture systems.
In vivo rodent models evaluating full-thickness cutaneous excision wounds demonstrate accelerated wound closure rates following topically applied or local administration of GHK-Cu. Histological analysis of treated tissue samples highlights enhanced re-epithelialization, elevated angiogenesis (measured by CD31 marker density), and increased accumulation of newly formed granulation tissue.
The anti-scarring properties of GHK-Cu are attributed to its capacity to attenuate fibrotic signal cascades. Animal models of hypertrophic scarring demonstrate that GHK-Cu treatment reduces the localized accumulation of dense, parallel collagen bundles, promoting a randomized, basket-weave orientation characteristic of normal uninjured dermis.
Additionally, preclinical studies suggest that GHK-Cu modulates inflammatory cell recruitment to the wound site. By regulating macrophage activity and suppressive cytokine production (such as TNF-alpha and IL-6), GHK-Cu helps transition the experimental wound bed from a persistent inflammatory state into an active proliferative phase.
When designing tissue regeneration and matrix remodeling experiments, researchers often compare GHK-Cu against other well-studied peptides in the class. Understanding the functional differences between these entities is critical for choosing the appropriate research tool.
While GHK-Cu primarily targets matrix remodeling, enzyme regulation, and collagen synthesis via copper transport, compounds like AHK-Cu 50mg show specific binding preferences in follicular epithelial models. Conversely, systemic tissue repair pathways are frequently investigated using non-copper peptides like BPC-157 or cell-migration stimulants like TB-500 10mg.
The table below highlights key functional differences among these tissue remodeling research compounds based on published preclinical literature:
For empirical data integrity, investigators must ensure that GHK-Cu preparations are free of free copper ions, truncated peptide fragments, and synthesis reagents. High-Performance Liquid Chromatography (HPLC) is employed to confirm chemical purity, ensuring that target peptide peaks account for greater than 98% of the relative area.
Mass Spectrometry (MS) is simultaneously utilized to verify exact molecular mass, confirming correct copper coordination and peptide sequence sequence identity. PX1 Research provides lot-specific certificates of analysis (COAs) for every batch, documenting exact molecular weights, HPLC chromatograms, and mass spectra.
In addition to purity metrics, bacterial endotoxin screening via Chromogenic Limulus Amebocyte Lysate (LAL) testing guarantees that endotoxin levels remain below strictly defined laboratory limits (<0.05 EU/mg). This prevents false-positive inflammatory responses in cell culture assays or animal studies. Institutional buyers managing high-volume procurement programs can explore custom specifications through our wholesale lab portal.
GHK-Cu is supplied as a lyophilized, deep-blue powder due to the presence of the chelated copper ion. To maintain product integrity, lyophilized vials should be stored at -20°C upon receipt in a dry, dark environment protected from moisture ingress.
Reconstitution should be performed under a laminar flow hood using sterile laboratory solvents such as Bacteriostatic Water, Sterile Water for Injection, or Phosphate-Buffered Saline (PBS, pH 7.4). Avoid high-shear vortexing; gentle swirly inversion is recommended to completely dissolve the lyophilized cake.
Once reconstituted, aqueous solutions of GHK-Cu should be aliquoted into single-use polypropylene tubes to prevent repeated freeze-thaw cycles. Reconstituted aliquots remain stable at 4°C for short-term experimentation (up to 14 days) or at -80°C for long-term storage. Avoid exposure to strong chelating agents (such as EDTA) or strong reducing agents in culture media, as these can strip the bound copper ion from the peptide core.
PX1 Research serves as a trusted domestic supplier for university laboratories, biotechnology enterprises, and clinical research institutions across North America. Our commitment to strict analytical standards ensures that researchers receive consistent, highly reproducible compounds for critical assays.
Every batch of GHK-Cu 100mg is synthesized in cGMP-compliant facilities within the USA and tested by independent ISO 17025 accredited analytical laboratories. We maintain complete batch traceability from raw amino acid coupling through final lyophilization and packaging.
To support ongoing trial schedules, PX1 Research provides same-day fulfillment for orders placed before 3 PM EST, shipping directly from distribution hubs in California and Arizona. Detailed documentation and structural validation data are available for download through our central PX1 research hub.
What is the purity level of GHK-Cu 100mg from PX1 Research?
PX1 Research supplies GHK-Cu 100mg at a verified purity level of ≥98%, confirmed by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (MS).
How is GHK-Cu 100mg shipped to US laboratories?
Orders ship directly from our domestic logistics centers in California and Arizona via expedited domestic carriers. Orders placed Monday through Friday before 3 PM EST are processed for same-day dispatch.
What documentation accompanies PX1 Research GHK-Cu?
Every lot of GHK-Cu includes a lot-specific Certificate of Analysis (COA) detailing HPLC purity chromatograms, mass spectrometry confirmation, heavy metal screening, and endotoxin assay results.
What solvent is recommended for reconstituting GHK-Cu for in vitro research?
Reconstitution is typically performed using sterile laboratory grade water, bacteriostatic water, or phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the specific cell culture or assay protocol.
Why is lyophilized GHK-Cu blue in appearance?
The deep blue color is characteristic of the complexed divalent copper ion (Cu2+) bound to the tripeptide matrix. Uncomplexed GHK peptide without copper appears white.
Can GHK-Cu be stored long-term after reconstitution?
Reconstituted aliquots should be stored at -80°C for extended stability. Repeated freeze-thaw cycles should be avoided to prevent peptide degradation or ion dissociation.
What are the primary preclinical research applications for GHK-Cu?
GHK-Cu is predominantly studied in vitro and in animal models for collagen and elastin synthesis, extracellular matrix remodeling, matrix metalloproteinase regulation, and anti-fibrotic wound healing.
Are PX1 Research compounds approved for human administration?
No. All products supplied by PX1 Research, including GHK-Cu 100mg, are strictly intended for laboratory research and development use only. They are not for human or veterinary diagnostic, therapeutic, or clinical application.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.